Strategic management of populations of interacting biological species routinely requires interventions combining multiple treatments or therapies. This is important in key research areas such as ecology, epidemiology, wound healing and oncology.
In Equation (1) all growth and decay terms are presented as functions of 71 both species. These terms can be reduced to functions of a single species to as [3, 5, 15, 52] , and extends readily to multiple control problems. As such, we present here only a brief outline of the process, and focus this work on in-139 sights and issues of practical implementation of multiple optimal controls. We 140 construct the Hamiltonian and appropriate co-state equations that couple the 141 objective and cost to the multi-species system. Applying the PMP produces a 142 two-point boundary value problem (TPBVP) that we must solve, in combina-143 tion with known initial conditions for the state, {S 1 (t 0 ), S 2 (t 0 )}, to minimise 144 the Hamiltonian and hence determine the optimal controls and corresponding 145 optimal state trajectories. The TPBVPs arising in optimal control are typ- 146 ically characterised as being a system of differential equations where some 147 initial conditions and some final time conditions are known. As such, they 148 are commonly solved using iterative approaches such as the forward-backward 149 sweep method (FBSM) or shooting methods [40, 52] . 150 We apply the FBSM, an iterative process involving the following steps: an 151 initial guess is made for the controls over the interval; using this guess the 152 state is solved forwards in time from t 0 to t f ; with this information and the 153 transversality condition (a final time constraint on the co-state variables, de-154 rived from the pay-off function), the co-state equations are solved backwards 155 in time from t f to t 0 , and; the guess for the controls are updated based on the 156 solutions for the state and co-state. This process is repeated until the state, ascribed to a small leukaemic burden, meaning optimal control regimes de-185 rived from a pay-off with a quadratic leukaemia term may reach a state where 186 significant leukaemia remains. Conversely, the penalty applied by a linear term 187 is proportional to the size of the leukaemic burden; optimal control regimes 188 derived under this type of pay-off will typically produce final states with less 189 leukaemia remaining.
190
In the following sections, we explore the dynamics of multiple controls through 
The competition between progenitor blood cells and leukaemic stem cells is 261 based on the hypothesis that these cells occupy the same niche within the (3). We consider scaled populations such that 0 ≤ A + L ≤ 1 in absence of 286 control, for suitably chosen initial conditions: A(0) + L(0) < 1 and L(0) 0.9.
The and controls is crucial for determining appropriate management strategies.
299
As such, we are particularly interested the parameter κ, that describes the 300 effectiveness of the chemotherapy in killing progenitor blood cells, relative to 301 leukaemic stem cells; κ < 1 corresponds to chemotherapy that is more effective 302 at killing leukaemic stem cells than progenitor blood cells, κ = 1 corresponds 303 to chemotherapy that is equally effective at killing either cell type and κ > 1 304 corresponds to chemotherapy that is more effective at killing progenitor blood Fig. 1 . Numerical solutions are presented for Equation (3) to demonstrate the model dynamics for different initial conditions, in absence of control. Initial conditions in (a) correspond to the coexisting steady state. In (b) we observe that a small leukaemic population is depleted through the immune response and competition with progenitor blood cells. In (c) we observe that a small progenitor blood cell population is replenished from haematopoietic stem cells, such that the model tends toward the coexisting steady state.
313
Due to the significant cost and side effects associated with each treatment, 314 we typically define pay-offs that minimise not only the leukaemic burden but 315 also the amount of each control applied. In the remainder of this section we 316 identify and discuss several reasonable choices of pay-off. We model two con- and are named as such because the optimal control takes either the lower or 323 upper bound, with finitely many discontinuous switching points throughout 324 the interval. We also apply bounds on the continuous controls. Bounds are 325 used to incorporate practical constraints such as a maximum tolerated dose.
326
In this work, we apply a lower bound of zero to all controls, corresponding to respectively.
334
The pay-offs we consider in this work can be expressed in a general form as:
We focus our investigation on the combinations of continuous and bang-bang x ∈ (0, 1)). arises from the pay-off in Equation (4) with p = 1 and q = 2. Noting that each control impacts the state differently (u reduces both A and L while v 375 increases A only), we can expect this to produce different dynamics to the 376 combination considered in the previous part with p = 2 and q = 1.
Continuous chemotherapy control, continuous stem cell transplant con-

377
We present results exploring the effect of the final time on the dynamics of the 378 bang-bang chemotherapy control in Figure S5 of the supplementary material.
379
In Figure S6 of the supplementary material we investigate how different upper 380 bounds on the continuous stem cell transplant control impact the dynamics. Finally, we investigate the case where both controls enter the pay-off linearly, 383 such that both optimal controls are bang-bang. This corresponds to Equation
384
(4) with p = 1 and q = 1.
385
In Figure S7 of the supplementary material, we investigate the impact of 386 increasing the upper bound on each of the bang-bang controls, effectively 387 allowing for stronger doses of each treatment to be applied. In Figure S8 In Figure 4 (b) we observe that for particular pay-off weightings it is possible 441 to recover similar behaviour through optimal control solutions to the model.
442
It is also interesting to note the transience of this result within the pay-off 443 weighting parameter space. In Figure 4 Fig. 4 . Under particular pay-off weightings, we observe that the stem cell transplant control is applied as the chemotherapy treatment is stopped. Solutions are presented corresponding to the pay-off given in Equation 4 with p = 1, q = 1, r = 2 and upper control bounds u b = v b = 0.3.
